AxoGen

Traded on the St. Petersburg Stock Exchange
AxoGen is a developer of surgical solutions, including human tissue grafts.
AxoGen stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

AxoGen balance sheet

Report period2018 2019 2020 2021 2022Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

AxoGen cash flows

Report period2018 2019 2020 2021 2022Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

AxoGen multipliers

Report period2018 2019 2020 2021 2022Q3 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

AxoGen profitability

Report period2018 2019 2020 2021 2022Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
AxoGen assets
AxoGen cash flows

AxoGen shares

TickerNameTypeNominal valueISINPrice
AXGN:USAxoGen, Inc.Common share-US05463X1063$14.46
AxoGen news
05.05.2022
AxoGen's GAAP loss for the 3 months of 2022 was $11.475 million, up 72.3% from $6.66 million in the prior year. Revenue decreased 0.1% to $31.007 million from $31.037 million a year earlier.
Source: {source} pictogram ir.axogeninc.com
Pictogram next
23.02.2022
AxoGen's GAAP loss for 2021 was $26.985 million, up 13.4% from $23.786 million in the previous year. Revenue increased 13.4% to $127.358 million from $112.3 million a year earlier.
Source: {source} pictogram ir.axogeninc.com
Pictogram next
04.11.2021
AxoGen's GAAP loss for 9M 2021 was $21.699 million, up 22.1% from $17.776 million in the previous year. Revenues increased 20.1% to $95.821 million from $79.805 million a year earlier.
Source: {source} pictogram ir.axogeninc.com
Pictogram next
04.08.2021
AxoGen's GAAP loss for the six months of 2021 was $14.558 million, down 10.7% from $16.297 million in the previous year. Revenue increased 39.3% to $64.617 million from $46.377 million a year earlier.
Source: {source} pictogram ir.axogeninc.com
Pictogram next
All AxoGen news
General information
Company nameAxoGen
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies
Business address13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Mailing address13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Websitewww.axogeninc.com
Information disclosurewww.sec.gov